BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4349977)

  • 1. Angiotensins lung converting enzyme.
    Loyke HF
    Proc Soc Exp Biol Med; 1973 May; 143(1):82-4. PubMed ID: 4349977
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation of nephrotensin from the renin angiotensin system.
    Susic D; Sparks JC
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):958-61. PubMed ID: 165547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the liver in the regulation of plasma angiotensinogen and renin levels.
    Tateishi H; Masson GM
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):304-9. PubMed ID: 4109091
    [No Abstract]   [Full Text] [Related]  

  • 4. The pressor response to serum and exogenous renin in rats.
    Loyke HF
    J Lab Clin Med; 1967 Jun; 69(6):1013-7. PubMed ID: 4290585
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy by angiotensin converting enzyme inhibitor in reduced renal mass hypertensive rats.
    Nakamura F; Nagano M; Higaki J; Higashimori K; Katahira K; Morishita R; Mikami H; Ogihara T
    J Hypertens Suppl; 1991 Dec; 9(6):S398-9. PubMed ID: 1840202
    [No Abstract]   [Full Text] [Related]  

  • 6. Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy.
    Marks ES; Bing RF; Thurston H; Russell GI; Swales JD
    Hypertension; 1982; 4(2):238-44. PubMed ID: 6279494
    [No Abstract]   [Full Text] [Related]  

  • 7. Converting enzyme in rat serum.
    Loyke HF
    Proc Soc Exp Biol Med; 1970 May; 134(1):248-51. PubMed ID: 4316389
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma.
    Nussberger J; Flückiger JP; Hui KY; Evéquoz D; Waeber B; Brunner HR
    J Hypertens Suppl; 1991 Dec; 9(6):S230-1. PubMed ID: 1818955
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the renin-angiotensin system in pathogenesis of experimental renal hypertension.
    Fujii J; Ikeda M
    Jpn Circ J; 1971 May; 35(5):493-8. PubMed ID: 4326116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system in an infant with malignant renovascular hypertension.
    Fyhrquist F; Kuitunen P; Kojo N
    Helv Paediatr Acta; 1976 Jun; 31(1):61-5. PubMed ID: 939701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide, arginine vasopressin, and the renin-angiotensin system in carbon tetrachloride-induced hepatitis in rats.
    Elias AN; Vaziri ND; Pandian MR; Domurat E; Ansari MA; Yazdani M
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):401-8. PubMed ID: 2972033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure.
    Davies DL; Beevers DG; Briggs JD; Medina AM; Robertson JI; Schalekamp MA; Brown JJ; Lever AF; Morton JJ; Tree M
    Lancet; 1973 Mar; 1(7805):683-6. PubMed ID: 4120488
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma renin activity and blood pressure before and after renal denervation.
    Mogil RA; Itskovitz HD; Russell JH; Murphy JJ
    Invest Urol; 1970 Mar; 7(5):442-7. PubMed ID: 4314538
    [No Abstract]   [Full Text] [Related]  

  • 15. [Angiotensin I-converting enzyme activity; determination methods and current topics].
    Kurihara H
    Saishin Igaku; 1971 Nov; 26(11):2044-53. PubMed ID: 4334937
    [No Abstract]   [Full Text] [Related]  

  • 16. ROLE OF THE LIVER IN EXPERIMENTAL RENAL HYPERTENSION: STUDY ON INACTIVATING ABILITY OF THE VASOACTIVE SUBSTANCE FOLLOWING RENO-PORTAL VENOUS ANASTOMOSIS.
    TABATA F
    Kobe J Med Sci; 1963 Sep; 41():93-134. PubMed ID: 14092169
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the renin-angiotensin system in normotensive and hypertensive rats with varying renin status.
    Atkinson J; Boillat N; Essadki A; Lüthi P; Maranda B; Sonnay M
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):301-15. PubMed ID: 3555376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EXPERIMENTAL HYPERTENSIONS TREATED WITH CCL-4: MEASUREMENTS OF ADRENAL FUNCTION, VASCULAR RESPONSIVENESS, ANGIOTENSINASE AND CONVERTING ENZYME.
    LOYKE HF
    Proc Soc Exp Biol Med; 1964 Apr; 115():1035-40. PubMed ID: 14166553
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
    Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.